Hutch News

Hutch News

Stories tagged 'Gary Lyman'

New guidelines take aim at chemo-related nausea

Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?

Aug. 24, 2017 | By Diane Mapes / Fred Hutch News Service

Nausea and vomiting is a weird thing to … uh … bring up, writes cancer survivor Diane Mapes. But a lot of people don't seem to realize these common chemo side effects are now well controlled with anti-nausea drugs. New guidelines, co-written by Fred Hutch's Dr. Gary Lyman, break it all down.

View story >


Surviving cancer without going broke

HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more

April 11, 2017 | By Diane Mapes / Fred Hutch News Service

About 200 patients, payers, providers and policymakers gathered with Fred Hutch researchers April 7 to discuss ways to bump value and bring down costs of cancer care. The day-long event marked the fourth Value in Cancer Care Summit, sponsored by the Hutchinson Institute for Cancer Outcomes Research.

View story >


Looking back at the future

A roundup of some of our favorite 2016 stories on research at Fred Hutch

Dec. 30, 2016 | By Fred Hutch News Service staff

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 21, 2016

Good News: Ceballos honored for public health research; ACS research awards to three Hutch scientists; ASH grant to physician-researcher Halpern; Paulovich facilitates Moonshot panel

View story >


Can Rx monopolies be tamed?

Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it

Aug. 23, 2016 | By Bill Briggs / Fred Hutch News Service

A new study blames “government-protected monopolies” granted to drug makers for fueling the surge in prescription prices ― a trend that’s hitting American patients hardest of all.

View story >


The sexual aftermath of cancer

From impotence to ‘chemopause’ to missing body parts, treatment side effects can mess with patients’ sex lives — why don’t we talk about it more?

July 28, 2016 | By Diane Mapes / Fred Hutch News Service

From impotence to "chemopause" to missing body parts, the side effects of cancer treatment can really mess with someone's sex life. But do we talk about it? Not so much. It's the elephant in the bedroom.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.